A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris
Status:
Completed
Trial end date:
2020-11-21
Target enrollment:
Participant gender:
Summary
The bioequivalence and safety of Tretinoin Cream 0.025% (Taro Pharmaceuticals U.S.A, Inc.)
and RETIN-A® (Tretinoin) Cream 0.025% in the treatment of acne vulgaris.